Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MacroGenics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MGNX
Nasdaq
2834
https://www.macrogenics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MacroGenics Inc
MacroGenics to Participate in Upcoming Investor Conferences
- May 13th, 2024 11:30 am
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
- May 12th, 2024 1:42 pm
Macrogenics Stock Drops 77% After Study Deaths
- May 10th, 2024 8:51 pm
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
- May 10th, 2024 7:29 pm
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
- May 10th, 2024 7:17 pm
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
- May 10th, 2024 6:15 am
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
- May 9th, 2024 8:01 pm
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
- May 3rd, 2024 11:30 am
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
- Apr 19th, 2024 11:04 am
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
- Apr 3rd, 2024 8:30 pm
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript
- Mar 14th, 2024 12:18 pm
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
- Mar 9th, 2024 6:09 pm
Q4 2023 MacroGenics Inc Earnings Call
- Mar 8th, 2024 12:19 pm
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
- Mar 8th, 2024 5:30 am
Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ...
- Mar 8th, 2024 3:42 am
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates
- Mar 7th, 2024 10:30 pm
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
- Mar 7th, 2024 9:01 pm
Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX)
- Mar 7th, 2024 4:29 am
Are Investors Undervaluing MacroGenics, Inc. (NASDAQ:MGNX) By 48%?
- Mar 2nd, 2024 1:09 pm
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for
- Feb 29th, 2024 3:00 pm
Scroll